Turning Point Therapeutics: Q2 Earnings Snapshot

August 8, 2022 GMT

SAN DIEGO (AP) _ Turning Point Therapeutics Inc. (TPTX) on Monday reported a loss of $123.1 million in its second quarter.

The San Diego-based company said it had a loss of $2.48 per share.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.78 per share.

The biopharmaceutical company posted revenue of $119,000 in the period.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TPTX at https://www.zacks.com/ap/TPTX